Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoluo Pills Combined with Iguratimod for Rheumatoid Arthritis
NCT07115641Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Aug 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of Huoluo Pills in rheumatoid arthritis (RA) (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: Proportion of subjects achieving ACR20 at 84 days. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Huoluo Pills
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07115641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07115641.